Fundraising FoxAerion Bioscience
1 known investors
Find your way into Aerion Bioscience
Aerion Bioscience develops a 6-protein biomarker panel for early detection and staging of lung cancer. The company is conducting clinical testing to validate the panel's ability to detect lung cancer, distinguish its stages and aggressiveness, and identify other lung conditions.
Founders & leadership
Investors · 1
In the news
Frequently asked questions
- What does Aerion Bioscience do?
- Aerion Bioscience develops a 6-protein biomarker panel for early detection and staging of lung cancer. The company is conducting clinical testing to validate the panel's ability to detect lung cancer, distinguish its stages and aggressiveness, and identify other lung conditions.
- Who are Aerion Bioscience's investors?
- Aerion Bioscience's investors include NLC.